EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access

Trade‐Off Between Early Reperfusion and First‐Pass Effect With Tenecteplase Versus Alteplase Before Stroke Thrombectomy

Tyler M Bielinski, Kelsey E Kline iD, Veronica N Bohl, Grant N Badger, Sina Hemmer, Wysteria Stedman, Oded Goren, Jiang Li iD, Clemens M Schirmer iD, Philipp Hendrix iD

Journal of the American Heart Association · 21.07.2026 · 15 (14)

DOI: 10.1161/jaha.125.047112 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 21.07.2026. Verfasst von Tyler M Bielinski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geisinger Commonwealth School of Medicine Scranton PA. Hauptthemen laut MEDLINE: Tenecteplase, Tissue Plasminogen Activator, Fibrinolytic Agents, Thrombectomy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early reperfusion and first‐pass effect are key procedural end points in large‐vessel occlusion stroke thrombectomy. Because of greater fibrin specificity, tenecteplase may achieve higher early reperfusion rates compared with alteplase, yet impact of thrombolytic agents on first‐pass effect remains unclear.

Methods

Consecutive patients with anterior circulation large‐vessel occlusion stroke receiving intravenous thrombolysis before endovascular treatment at 2 US stroke centers were reviewed. Early reperfusion was defined as extended Thrombolysis in Cerebral Infarction ≥2b50 on initial angiography. First‐pass effect was defined as extended Thrombolysis in Cerebral Infarction 2c‐3 after a single pass. Multivariable logistic regression identified predictors of early reperfusion and first‐pass effect. Ordinal logistic regression assessed associations of thrombolytic agent, early reperfusion, and first‐pass effect with 90‐day modified Rankin Scale shift.

Results

Among 299 patients (tenecteplase 201, alteplase 98), early reperfusion occurred in 60 (20.1%) and was more frequent with tenecteplase compared with alteplase (24.4% versus 11.2%; adjusted odds ratio [OR], 2.31 [95% CI, 1.07–4.98]). Patients without early reperfusion were evaluated for first‐pass effect. Of 237 patients, first‐pass effect was less frequent with tenecteplase compared with alteplase (30.3% versus 40.2%; adjusted OR, 0.42 [95% CI, 0.23–0.79]). Early reperfusion and first‐pass effect each independently predicted better functional outcome, but functional outcomes were similar between tenecteplase and alteplase overall.

Conclusions

We observed higher early reperfusion rates with tenecteplase, but greater first‐pass effect with alteplase, while functional outcomes were comparable. This may suggest that the early reperfusion advantage of tenecteplase could be offset by downstream procedural variables such as first‐pass effect, highlighting the importance of jointly evaluating both reperfusion and procedural efficiency when comparing thrombolytic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenecteplaseTissue Plasminogen ActivatorFibrinolytic AgentsThrombectomyThrombolytic TherapyReperfusionStrokeIschemic StrokeHumansFemaleMaleAgedTreatment OutcomeTime FactorsRetrospective StudiesMiddle AgedAged, 80 and overLogistic ModelsOdds RatioMultivariate Analysis

Stichwörter der Autor:innen

alteplaseearly reperfusionlarge‐vessel occlusion stroketenecteplase

Substanzen

TenecteplaseTissue Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Geisinger Commonwealth School of Medicine Scranton PA.
  • Department of Neurosurgery Geisinger Medical Center Geisinger Danville PA.
  • Department of Neurosurgery Geisinger Wyoming Valley Medical Center Geisinger, Wilkes-Barre PA.
  • Neuroscience Institute Geisinger Danville PA.
  • Department of Molecular and Functional Genomics Weis Center for Research Geisinger, Danville PA.

ORCID-Profile: Kelsey E Kline, Jiang Li, Clemens M Schirmer, Philipp Hendrix

Zitieren

APA

Bielinski, T. M., Kline, K. E., Bohl, V. N., Badger, G. N., Hemmer, S., Stedman, W., Goren, O., Li, J., Schirmer, C. M., & Hendrix, P. (2026). Trade‐Off Between Early Reperfusion and First‐Pass Effect With Tenecteplase Versus Alteplase Before Stroke Thrombectomy. Journal of the American Heart Association, 15(14). https://doi.org/10.1161/jaha.125.047112

Vancouver

Bielinski TM, Kline KE, Bohl VN, Badger GN, Hemmer S, Stedman W, et al. Trade‐Off Between Early Reperfusion and First‐Pass Effect With Tenecteplase Versus Alteplase Before Stroke Thrombectomy. Journal of the American Heart Association. 2026;15(14). doi:10.1161/jaha.125.047112

BibTeX
@article{Bielinski2026,
  author = {Bielinski, Tyler M and Kline, Kelsey E and Bohl, Veronica N and Badger, Grant N and Hemmer, Sina and Stedman, Wysteria and Goren, Oded and Li, Jiang and Schirmer, Clemens M and Hendrix, Philipp},
  title = {Trade‐Off Between Early Reperfusion and First‐Pass Effect With Tenecteplase Versus Alteplase Before Stroke Thrombectomy},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1161/jaha.125.047112}
}
Kostenlos starten →